Enlightenment Research, LLC Novartis Ag Transaction History

Enlightenment Research, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $184,253 - $208,426	-2,300 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $183,310 - $202,699	2,300 New	2,300 $201,000
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $340,960 - $376,600	-4,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$83.5 - $98.47 $334,000 - $393,880	4,000 New	4,000 $342,000
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $295,704 - $327,600	-3,600 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$80.93 - $91.1 $291,348 - $327,960	3,600 New	3,600 $314,000
Q1 2019 May 03, 2019	SELL	$75.32 - $86.15 $256,087 - $292,910	-3,400 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$73.66 - $82.02 $250,444 - $278,868	3,400 New	3,400 $292,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Enlightenment Research, LLC, based on Form 13F filings with the SEC.

Stay updated on Enlightenment Research, LLC with notifications on news.